Viela Bio Revenue and Competitors
Estimated Revenue & Valuation
- Viela Bio's estimated annual revenue is currently $1.4M per year.
- Viela Bio received $250.0M in venture funding in March 2018.
- Viela Bio's estimated revenue per employee is $77,500
- Viela Bio's total funding is $357.3M.
- Viela Bio has 18 Employees.
- Viela Bio grew their employee count by 20% last year.
What Is Viela Bio?
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company's portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland. Learn more at www.vielabio.comkeywords:N/A
Number of Employees
Employee Growth %
Viela Bio News
... to witness significant growth over the forecast by 2028 | Alexion Pharmaceuticals Inc., Chugai Pharmaceutical Co., Ltd., Viela Bio, Inc.
... recently was vice president of clinical development at Horizon Therapeutics following its acquisition of Viela Bio, Inc. Prior to that,...
Most recently, he was Vice President, Clinical Development at Horizon Therapeutics following its acquisition of Viela Bio, Inc. At Horizon...
It's a pivotal moment for the MedImmune spinout, which has put the fate of its first prospective product in regulators' hands.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Viela Bio Funding